NGNE vs CBAN

Comparison between Neoleukin Therapeutics Inc (NGNE, Company) and Colony Bankcorp Inc (CBAN, Company).

NGNE is from the Healthcare sector, while CBAN is from the Financial Services sector.

5-Year PerformanceCBAN has outperformed NGNE, delivering a return of +6.7% compared to -32.5%

NGNE vs CBAN - Performance Comparison

Log

Key Characteristics

Financial metrics and valuation ratios

Metric	NGNE(COMPANY)	CBAN(COMPANY)
Market Cap	$437M	$437M
Max Drawdown	98.34%	94.72%
Sharpe Ratio	0.72	1.12
5Y Beta	1.88	0.80
Industry	Biotechnology	Banks - Regional
P/E Ratio	-4.28	15.50
Forward P/E	N/A	11.00
PEG Ratio	-0.34	0.97
Dividend Yield	N/A	2.27%
5Y Dividends CAGR	N/A	2.98%
5Y EPS CAGR	11.24%	0.89%
Debt to Equity	0.00%	0.00%
Free Cash Flow Yield	-19.02%	6.71%
P/S Ratio	438.73	3.16
P/B Ratio	1.86	1.14

Market Cap

Winner

NGNE

$437M

CBAN

$437M

Max Drawdown

NGNE

98.34%

Winner

CBAN

94.72%

Sharpe Ratio

NGNE

0.72

Winner

CBAN

1.12

5Y Beta

NGNE

1.88

Winner

CBAN

0.80

Industry

NGNE

Biotechnology

CBAN

Banks - Regional

P/E Ratio

Winner

NGNE

-4.28

CBAN

15.50

Forward P/E

NGNE

N/A

CBAN

11.00

PEG Ratio

Winner

NGNE

-0.34

CBAN

0.97

Dividend Yield

NGNE

N/A

CBAN

2.27%

5Y Dividends CAGR

NGNE

N/A

CBAN

2.98%

5Y EPS CAGR

Winner

NGNE

11.24%

CBAN

0.89%

Debt to Equity

NGNE

0.00%

CBAN

0.00%

Free Cash Flow Yield

NGNE

-19.02%

Winner

CBAN

6.71%

P/S Ratio

NGNE

438.73

Winner

CBAN

3.16

P/B Ratio

NGNE

1.86

Winner

CBAN

1.14

NGNE vs CBAN - Historical Returns

Returns include dividend reinvestment.

Period	NGNE	CBAN
1 month	-7.74%	+8.32%
3 months	+30.49%	+9.37%
6 months	+39.10%	+16.31%
1 year	+42.65%	+37.88%
5 years(CAGR)	-32.51%	+6.65%
10 years(CAGR)	-14.88%	+10.92%
Max(CAGR)	-15.77%	+4.46%

NGNE

-7.74%

Winner

CBAN

+8.32%

Winner

NGNE

+30.49%

CBAN

+9.37%

Winner

NGNE

+39.10%

CBAN

+16.31%

Winner

NGNE

+42.65%

CBAN

+37.88%

5Y(CAGR)

NGNE

-32.51%

Winner

CBAN

+6.65%

10Y(CAGR)

NGNE

-14.88%

Winner

CBAN

+10.92%

Max(CAGR)

NGNE

-15.77%

Winner

CBAN

+4.46%

NGNE vs CBAN - Annual Returns (1999 - 2026)

Returns include dividend reinvestment.

Year	NGNE	CBAN
2026	+44.35%	+20.51%
2025	-10.00%	+15.89%
2024	+15.05%	+27.54%
2023	+91.88%	+7.85%
2022	-90.27%	-24.67%
2021	-65.89%	+23.24%
2020	+18.99%	-4.17%
2019	+428.76%	+15.12%
2018	-82.00%	+2.64%
2017	-27.41%	+10.59%
2016	+33.90%	+37.93%
2015	+63.56%	+20.94%
2014	-37.24%	+29.18%
2013	N/A	+71.83%
2012	N/A	+71.43%
2011	N/A	-47.04%
2010	N/A	-10.44%
2009	N/A	-41.38%
2008	N/A	-46.37%
2007	N/A	-12.24%
2006	N/A	-27.16%
2005	N/A	-25.40%
2004	N/A	+70.45%
2003	N/A	+60.35%
2002	N/A	+21.68%
2001	N/A	+36.92%
2000	N/A	-24.56%
1999	N/A	+6.20%

NGNE vs CBAN Drawdown Comparison

The maximum drawdown for NGNE was -98.34%, occurring on Apr 8, 2025. This drawdown has not yet recovered.

The maximum drawdown for CBAN was -94.15%, occurring on Jan 17, 2012. This drawdown has not yet recovered.

The current NGNE drawdown is -93.43%. The current CBAN drawdown is -17.55%.

Rank	NGNE	CBAN
#1	-98.34% Aug 14, 2015 - Apr 8, 2025	-94.15% May 13, 2005 - Jan 17, 2012
#2	-89.57% Mar 12, 2014 - Aug 10, 2015	-32.21% Jan 14, 2000 - Jan 30, 2002
#3	-16.18% Aug 11, 2015 - Aug 14, 2015	-21.33% Sep 8, 2003 - Feb 6, 2004
#4	N/A	-15.54% Jul 12, 2002 - Jan 7, 2003
#5	N/A	-13.94% Dec 28, 2004 - May 9, 2005
#6	N/A	-13.24% Feb 25, 2003 - Jun 9, 2003
#7	N/A	-9.80% Nov 1, 1999 - Dec 28, 1999
#8	N/A	-8.82% Feb 6, 2004 - Apr 1, 2004
#9	N/A	-7.63% Apr 27, 2004 - Jun 21, 2004
#10	N/A	-7.41% Dec 30, 1999 - Jan 14, 2000
#11	N/A	-6.98% Jan 7, 2003 - Jan 27, 2003
#12	N/A	-6.41% Jan 31, 2002 - Apr 12, 2002
#13	N/A	-6.40% Nov 23, 2004 - Dec 16, 2004
#14	N/A	-5.99% May 8, 2002 - Jul 8, 2002
#15	N/A	-5.84% Apr 14, 2004 - Apr 27, 2004

Correlation

Correlation between NGNE and CBAN is -0.44 which considered as a weak negative correlation - the stocks show a slight tendency to move in opposite directions.

-0.44

-101